Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.
Identifieur interne : 001A91 ( Ncbi/Curation ); précédent : 001A90; suivant : 001A92Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.
Auteurs : Jason Boyd [États-Unis] ; Steven Sloan ; Jeffrey MeffertSource :
- Journal of drugs in dermatology : JDD [ 1545-9616 ]
Descripteurs français
- KwdFr :
- Abdomen, Acides nicotiniques (administration et posologie), Acides nicotiniques (usage thérapeutique), Administration par voie cutanée, Adulte d'âge moyen, Gels, Humains, Mâle, Obésité morbide (), Produits dermatologiques (administration et posologie), Produits dermatologiques (usage thérapeutique), Éléphantiasis (traitement médicamenteux), Éléphantiasis (étiologie).
- MESH :
- administration et posologie : Acides nicotiniques, Produits dermatologiques.
- traitement médicamenteux : Éléphantiasis.
- usage thérapeutique : Acides nicotiniques, Produits dermatologiques.
- étiologie : Éléphantiasis.
- Abdomen, Administration par voie cutanée, Adulte d'âge moyen, Gels, Humains, Mâle, Obésité morbide.
English descriptors
- KwdEn :
- Abdomen, Administration, Cutaneous, Dermatologic Agents (administration & dosage), Dermatologic Agents (therapeutic use), Elephantiasis (drug therapy), Elephantiasis (etiology), Gels, Humans, Male, Middle Aged, Nicotinic Acids (administration & dosage), Nicotinic Acids (therapeutic use), Obesity, Morbid (complications).
- MESH :
- chemical , administration & dosage : Dermatologic Agents, Nicotinic Acids.
- chemical , therapeutic use : Dermatologic Agents, Nicotinic Acids.
- complications : Obesity, Morbid.
- drug therapy : Elephantiasis.
- etiology : Elephantiasis.
- Abdomen, Administration, Cutaneous, Gels, Humans, Male, Middle Aged.
Abstract
Elephantiasis nostras verrucosa represents an uncommon yet distinct clinical entity resulting from chronic lymphedema of an extremity or body region. Characterized by profound non-pitting edema with cobblestone-like papules, plaques, and nodules, it typically occurs secondary to infections, surgeries, tumor obstruction, radiation, congestive heart failure, and obesity. This progressively deformative disorder has been treated with various medical and surgical measures. In the following case report, the history, clinical, and pathologic appearance of elephantiasis nostras verrucosa are discussed, as well as newer treatment options.
PubMed: 15303792
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003F34
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003F34
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003F34
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001A91
Links to Exploration step
pubmed:15303792Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.</title><author><name sortKey="Boyd, Jason" sort="Boyd, Jason" uniqKey="Boyd J" first="Jason" last="Boyd">Jason Boyd</name><affiliation wicri:level="2"><nlm:affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Uniformed Services University of the Health Sciences, Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Sloan, Steven" sort="Sloan, Steven" uniqKey="Sloan S" first="Steven" last="Sloan">Steven Sloan</name></author><author><name sortKey="Meffert, Jeffrey" sort="Meffert, Jeffrey" uniqKey="Meffert J" first="Jeffrey" last="Meffert">Jeffrey Meffert</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2004 Jul-Aug</MedlineDate></PubDate></date><idno type="RBID">pubmed:15303792</idno><idno type="pmid">15303792</idno><idno type="wicri:Area/PubMed/Corpus">003F34</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003F34</idno><idno type="wicri:Area/PubMed/Curation">003F34</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003F34</idno><idno type="wicri:Area/PubMed/Checkpoint">003F34</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003F34</idno><idno type="wicri:Area/Ncbi/Merge">001A91</idno><idno type="wicri:Area/Ncbi/Curation">001A91</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.</title><author><name sortKey="Boyd, Jason" sort="Boyd, Jason" uniqKey="Boyd J" first="Jason" last="Boyd">Jason Boyd</name><affiliation wicri:level="2"><nlm:affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Uniformed Services University of the Health Sciences, Bethesda, Maryland</wicri:regionArea><placeName><region type="state">Maryland</region></placeName></affiliation></author><author><name sortKey="Sloan, Steven" sort="Sloan, Steven" uniqKey="Sloan S" first="Steven" last="Sloan">Steven Sloan</name></author><author><name sortKey="Meffert, Jeffrey" sort="Meffert, Jeffrey" uniqKey="Meffert J" first="Jeffrey" last="Meffert">Jeffrey Meffert</name></author></analytic><series><title level="j">Journal of drugs in dermatology : JDD</title><idno type="ISSN">1545-9616</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abdomen</term><term>Administration, Cutaneous</term><term>Dermatologic Agents (administration & dosage)</term><term>Dermatologic Agents (therapeutic use)</term><term>Elephantiasis (drug therapy)</term><term>Elephantiasis (etiology)</term><term>Gels</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Nicotinic Acids (administration & dosage)</term><term>Nicotinic Acids (therapeutic use)</term><term>Obesity, Morbid (complications)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abdomen</term><term>Acides nicotiniques (administration et posologie)</term><term>Acides nicotiniques (usage thérapeutique)</term><term>Administration par voie cutanée</term><term>Adulte d'âge moyen</term><term>Gels</term><term>Humains</term><term>Mâle</term><term>Obésité morbide ()</term><term>Produits dermatologiques (administration et posologie)</term><term>Produits dermatologiques (usage thérapeutique)</term><term>Éléphantiasis (traitement médicamenteux)</term><term>Éléphantiasis (étiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Dermatologic Agents</term><term>Nicotinic Acids</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dermatologic Agents</term><term>Nicotinic Acids</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Acides nicotiniques</term><term>Produits dermatologiques</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Obesity, Morbid</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Elephantiasis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Éléphantiasis</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Acides nicotiniques</term><term>Produits dermatologiques</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Éléphantiasis</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Abdomen</term><term>Administration, Cutaneous</term><term>Gels</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Abdomen</term><term>Administration par voie cutanée</term><term>Adulte d'âge moyen</term><term>Gels</term><term>Humains</term><term>Mâle</term><term>Obésité morbide</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Elephantiasis nostras verrucosa represents an uncommon yet distinct clinical entity resulting from chronic lymphedema of an extremity or body region. Characterized by profound non-pitting edema with cobblestone-like papules, plaques, and nodules, it typically occurs secondary to infections, surgeries, tumor obstruction, radiation, congestive heart failure, and obesity. This progressively deformative disorder has been treated with various medical and surgical measures. In the following case report, the history, clinical, and pathologic appearance of elephantiasis nostras verrucosa are discussed, as well as newer treatment options.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A91 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001A91 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Curation
|type= RBID
|clé= pubmed:15303792
|texte= Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:15303792" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |